Similar Search Results

A primer on the economics of prescription pharmaceutical pricing in health insurance markets

Berndt, Ernst R.; McGuire, Thomas G.; Newhouse, Joseph P. - In: Forum for health economics & policy : an evolving … 14 (2011) 2, pp. 1-28

Persistent link: https://www.econbiz.de/10009620010

How much favorable selection is left in Medicare advantage?

Newhouse, Joseph P.; Price, Mary; McWilliams, J. Michael; … - 2014

Persistent link: https://www.econbiz.de/10010351986

Assessing incentives for service-level selection in private health insurance exchanges

McGuire, Thomas G.; Newhouse, Joseph P.; Normand, … - In: Journal of health economics 35 (2014), pp. 47-63

Persistent link: https://www.econbiz.de/10010468706

Integrating risk adjustment and enrollee premiums in health plan payment

McGuire, Thomas G.; Glazer, Jacob; Newhouse, Joseph P.; … - In: Journal of health economics 32 (2013) 6, pp. 1263-1277

Persistent link: https://www.econbiz.de/10010425172

A primer on the economics of prescription pharmaceutical pricing in health insurance markets

Berndt, Ernst R.; McGuire, Thomas G.; Newhouse, Joseph P. - 2011

Persistent link: https://www.econbiz.de/10008936343

Using performance measures to motivate 'report-averse' and 'report-loving' agents

Glazer, Jacob; McGuire, Thomas G.; Newhouse, Joseph P. - In: Journal of health economics 26 (2007) 6, pp. 1170-1189

Persistent link: https://www.econbiz.de/10003751556

A model of the impact of reimbursement schemes on health plan choice

Keeler, Emmett B. - In: Journal of health economics 17 (1998) 3, pp. 297-320

Persistent link: https://www.econbiz.de/10001249681

Has DRG creep crept up? : decomposing the case mix index change between 1987 and 1988

Carter, Grace M. - 1991

Persistent link: https://www.econbiz.de/10000845306

How much change in the case mix index is DRG creep?

Carter, Grace M. - 1990

Persistent link: https://www.econbiz.de/10000796937

A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets

Berndt, Ernst R. - 2011

The pricing of medical products and services in the U.S. is notoriously complex. In health care, supply prices (those received by the manufacturer) are distinct from demand prices (those paid by the patient) due to health insurance. The insurer, in designing the benefit, decides what prices...

Persistent link: https://www.econbiz.de/10013128277